Relationship between dyslipidaemia and glycaemic status in patients with Type 2 diabetes mellitus
S C Thambiah1, I N Samsudin, E George
1Universiti Putra Malaysia, Faculty of Medicine and Health Sciences, Department of Pathology, 43400, UPM Serdang, Selangor, Malaysia. subashini@upm.edu.my.
Insights
Glycated haemoglobin (HbA1c) levels are strongly linked to dyslipidaemia in type 2 diabetes patients. Higher HbA1c indicates a greater risk of cardiovascular disease, suggesting HbA1c can predict lipid issues.
Area of Science:
- Endocrinology
- Cardiology
- Metabolic Syndrome
Background:
- Diabetic patients face elevated coronary heart disease (CHD) risk due to atherogenic lipid profiles.
- Glycated haemoglobin (HbA1c) severity correlates with CHD in diabetics.
- Malaysian guidelines recommend HbA1c < 6.5% to reduce diabetic complications.
Purpose of the Study:
- To investigate the relationship between dyslipidaemia and glycaemic status in type 2 diabetes mellitus (T2DM) patients.
- To assess HbA1c as a potential biomarker for dyslipidaemia and cardiovascular disease (CVD) risk in T2DM.
Main Methods:
- Retrospective cross-sectional study of 214 T2DM patients with dyslipidaemia.
- Data collected from Hospital Putrajaya endocrine clinic (January 2009 - December 2012).
- Analysis of correlations between fasting blood glucose (FBG), HbA1c, and various lipid parameters (TC, TG, LDL, non-HDL, LDL/HDL, TC/HDL).
Main Results:
- Significant correlations found between FBG and HbA1c with all measured lipid parameters, with HbA1c showing stronger correlations.
- Patients with HbA1c ≥ 6.5% had significantly higher TC, TG, non-HDL, and TC/HDL ratios.
- Statin treatment was associated with significantly lower non-HDL, LDL/HDL, TC/HDL ratios, and HbA1c levels.
Conclusions:
- Glycaemic status is significantly associated with dyslipidaemia in T2DM patients.
- HbA1c may serve as a valuable biomarker for dyslipidaemia.
- HbA1c could be a potential indirect predictor of CVD risk in T2DM patients.
Abstract:
The risk of coronary heart disease (CHD) is dramatically increased in diabetic patients due to their atherogenic lipid profile. The severity of CHD in diabetic patients has been found to be directly associated with glycated haemoglobin (HbA1c). According to the Malaysian Clinical Practice Guidelines on diabetes mellitus (DM), HbA1c level less than 6.5% reduces the risk of microvascular and macrovascular complications. Hence, this study aimed to determine the relationship between dyslipidaemia and glycaemic status in patients with type 2 DM (T2DM) patients in Hospital Putrajaya, a tertiary endocrine centre in Malaysia. This was a cross sectional, retrospective study of 214 T2DM patients with dyslipidaemia who had visited the endocrine clinic between January 2009 and December 2012. Significant correlations were found between fasting blood glucose (FBG) and HbA1c with total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL), non-high density lipoprotein cholesterol (non-HDL), LDL/HDL ratio and TC/HDL ratio; greater correlation being with HbA1c than FBG. In patients with HbA1c ≥ 6.5%, TC, TG, non-HDL and TC/HDL ratio were significantly higher than in patients with HbA1c < 6.5%. Non-HDL, LDL/HDL ratio, TC/HDL ratio and HbA1c were significantly lower in patients on statin treatment than nontreated patients (p<0.05). This significant association between glycaemic status and dyslipidaemia emphasises the additional possible use of HbA1c as a biomarker for dyslipidaemia as well as a potential indirect predictor of cardiovascular disease (CVD) risk in T2DM patients.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
